3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

le Roux, Carel W, Prof ; Astrup, Arne, Prof ; Fujioka, Ken, MD ; Greenway, Frank, Prof ; Lau, David C W, Prof ; Van Gaal, Luc, Prof ; Ortiz, Rafael Violante, MD ; Wilding, John P H, Prof ; Skjøth, Trine V, MD ; Manning, Linda Shapiro, MD ; Pi-Sunyer, Xavier, Prof

The Lancet (British edition), 2017-04, Vol.389 (10077), p.1399-1409 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible